Frost & Sullivan releases the 'China Biopharmaceutical Market Research Report'

Based on research into the Chinese biopharmaceutical market, Frost & Sullivan (Frost & Sullivan) has released a related industry report. The report indicates that due to the excellent efficacy of biopharmaceuticals, significant development in biotechnology, and increasing R&D investment, the global biopharmaceutical market size grew from $194.4 billion in 2014 to $261.8 billion in 2018, with an annual compound growth rate of 7.7% from 2014 to 2018. The Chinese biopharmaceutical market is still in its early stages of development but has strong growth potential, leading the overall pharmaceutical market growth rate. In 2018, the Chinese biopharmaceutical market size reached 262.2 billion yuan. For more content, please refer to 'Research Report on the Chinese Biopharmaceutical Market'.